Episodes

  • Pfizer’s Alex Condoleon on medical affairs accountability
    Oct 22 2026

    Pfizer’s chief medical affairs officer talks about measuring medical affairs’ true impact, leading change at scale, and what patient-first really means.

    See www.mckinsey.com/privacy-policy for privacy information

    Show More Show Less
    47 mins
  • Novartis’s Christian Diehl on scaling AI beyond the demo
    Sep 17 2026

    Novartis’s chief data and digital officer for biomedical research explains how data platform investments are paying off in AI safety prediction, generative chemistry, and faster translation

    See www.mckinsey.com/privacy-policy for privacy information

    Show More Show Less
    42 mins
  • AstraZeneca's Bob Li on the MARS mission to eliminate cancer
    Aug 31 2026

    Bob Li, AstraZeneca's Senior Vice President, Global Head of Medical Affairs, Oncology, on why only seven percent of cancer patients get access to clinical trials, and what decentralized trials, AI, and international collaboration could do to change that within a decade.

    See www.mckinsey.com/privacy-policy for privacy information

    Show More Show Less
    38 mins
  • McKinsey’s Fangning Zhang on China’s growing role in life sciences R&D
    Aug 24 2026

    McKinsey partner Fangning Zhang discusses what’s driving China’s acceleration in drug discovery, why intense competition is fueling speed and cost efficiency, and what global R&D leaders need to do to build a genuine China strategy.

    See www.mckinsey.com/privacy-policy for privacy information

    Show More Show Less
    28 mins
  • Bayer’s Sai Jasti on driving productivity in R&D with data science and AI
    Jul 28 2026

    Bayer’s Senior Vice President and Head of Data Science and AI, Sai Jasti, on how the company is transforming its workflows and embedding AI in research and development to meet ambitious productivity goals.

    See www.mckinsey.com/privacy-policy for privacy information

    Show More Show Less
    31 mins
  • Bristol Myers Squibb CDTO Greg Meyers on biopharma’s AI-enabled future
    Nov 5 2025

    Greg Meyers, Executive Vice President and Chief Digital & Technology Officer at Bristol Myers Squibb (BMS) discusses how technology can be leveraged to drive outcomes.

    See www.mckinsey.com/privacy-policy for privacy information

    Show More Show Less
    30 mins
  • Lykke Hinsch Gylvin on the cutting edge of clinical trial design
    Oct 6 2025

    Lykke Hinsch Gylvin shares how Boehringer Ingelheim’s innovative clinical trial designs bring therapies to patients faster.

    See www.mckinsey.com/privacy-policy for privacy information

    Show More Show Less
    24 mins
  • Genentech’s John Marioni on enhancing drug discovery with data and AI
    Jun 6 2025

    John Marioni discusses how he and his teams across industries and academia use evolving technologies to bring sophisticated drug therapies to patients.

    See www.mckinsey.com/privacy-policy for privacy information

    Show More Show Less
    32 mins